Organelle interplay in cardiovascular diseases: Mechanisms, pathogenesis, and therapeutic perspectives

Han Wu1, Hongtao Diao1, Feng Zhang1

  • 1Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.

Insights

Cardiovascular diseases stem from organelle dysfunction within heart cells. Understanding these cellular interactions offers new therapeutic targets for heart disease.

Area of Science:

  • Cardiovascular biology
  • Cellular organelle interactions
  • Cardiac pathology

Background:

  • Cardiovascular diseases (CVDs) are a major global health burden, with limited understanding of their pathogenesis.
  • The heart comprises diverse cells, including cardiomyocytes, where organelle dysfunction critically impacts cardiac health.
  • Inter-organelle communication is vital for cellular homeostasis, and its disruption is implicated in various diseases.

Purpose of the Study:

  • To review how organelle interplay within cardiomyocytes is altered in heart diseases.
  • To identify underexplored signaling pathways governing organelle communication in CVDs.
  • To evaluate potential therapies targeting organelle interactions for improved CVD treatment.

Main Methods:

  • Literature review focusing on organelle communication in cardiovascular diseases.
  • Analysis of studies detailing cellular and molecular mechanisms of organelle dysfunction in the heart.
  • Synthesis of current research on therapeutic strategies aimed at restoring organelle crosstalk.

Main Results:

  • Organelle dysfunction and altered communication are key contributors to cardiac pathologies in CVDs.
  • Specific signaling pathways regulating organelle crosstalk in the heart remain incompletely understood.
  • Emerging therapeutic strategies show promise in modulating organelle interactions for CVD management.

Conclusions:

  • Restoring normal organelle interplay in cardiomyocytes presents a promising avenue for novel CVD therapies.
  • Further research into signaling pathways governing organelle communication is crucial for clinical translation.
  • Addressing gaps in understanding organelle interactions can provide a basis for improved cardiovascular disease outcomes.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
499
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
325
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
23